Search
for
Sort by
Research 721–750 of 1000+
- Hypothyroidism in Dogs
- Telogen Effluvium
- The genetically programmed hair growth cycle and alopecia: what is there to know?
- Clinical Hair Loss: Diagnosis and Treatment
- Lichen sclerosus et atrophicus and autoimmunity in 250 women
- Nonscarring hair loss disorders
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives
- Prevalence of anti-thyroid peroxidase antibodies among women with polycystic ovary syndrome
- Applications of Antioxidant Nanoparticles in Immune-Mediated Inflammatory Diseases
- Serum-Based Assessment of Alopecia Areata Response to Treatment Using ATR-FTIR Spectroscopy
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- Alopecia Universalis in a Multiple Sclerosis Patient After Switching From Rituximab to Ocrelizumab: A Case Report
- A retrospective clinical and laboratory analysis including vitamin D and antinuclear antibodies in central centrifugal cicatricial alopecia and nonscarring alopecia in African Americans
- ALOPECIA AREATA: PADRÕES DE QUEDA DE CABELO, MODALIDADES DE TRATAMENTO E IMPACTO PSICOLÓGICO
- PERSPECTIVAS ACTUALES EN EL TRATAMIENTO DE LA ALOPECIA AREATA
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Janus kinase inhibitors for alopecia areata: A narrative review
- Increased risk of alopecia areata in patients with autism spectrum disorders: A Korean nationwide population-based study
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Alopecia Areata Barbae in a Nutshell
- Use of Hydroxychloroquine in Hair Disorders
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- Frontal fibrosing alopecia: A review of disease pathogenesis
- Dupilumab for alopecia areata treatment: A double‐edged sword?
- Increased proliferation of epidermal gamma delta T cells and expression of the transmembrane protein, BST2, in Alopecia areata
- Alopecia areata – Aktuelles Verständnis und Management
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study
- Koilonychia in a Patient with Alopecia Areata.